LIBSTAR HOLDINGS LIMITED - Unaudited Interim Results for the Six-Month Period ended 30 June 2026
What this filing means
A result that met the lowered bar but still reads as a deterioration. Libstar's Normalised EBITDA of R453.2m landed inside the R446.1m–R460.3m range guided 19 days earlier, yet Basic EPS fell 47.3% and cash conversion collapsed from 107% to 70%. The operational underperformance was concentrated in Dickon Hall Foods and Dry Condiments, while the share had already sold off 25.7% into the print — so the bad news was largely anticipated, even if the cash-flow damage was not.
Libstar told the market three weeks ago that earnings would fall, and the actual numbers landed roughly where it said they would. The worrying part is that the company is turning far less of its profit into actual cash — cash conversion dropped from 107% to 70% — and it is spending much more on new equipment at the same time. The pre-filing price move is context only and does not show what the market expected.
Bull case
- Normalised EBITDA of R453.2m landed within the trading statement range of R446.1m-R460.3m, meeting the bar set 19 days earlier.
- Post-period disposal of the Phesantekraal property raised R65m, incrementally strengthening an already conservative balance sheet.
Bear case
- Cash conversion collapsed to 70% from 107%, signalling severe deterioration in cash generation far worse than the 4.3% EBITDA decline.
- Basic EPS fell 47.3% to 8.8 cents and Basic HEPS fell 29.1% to 12.9 cents, with Normalised EPS also down 13.4% — earnings power is materially impaired.
- Capex surged 73.6% to R145.3m while cash from operations dropped 31.9% to R342.8m, compressing free cash flow and raising funding pressure.
- Value-added Meats remains structurally under pressure from chicken capacity constraints and beef underutilisation, with the manufacturing capacity review only due to complete in H2 2026 — the fix is deferred.
- No quantified H2 2026 or FY2026 outlook numbers are provided, leaving the market unable to anchor recovery expectations against the bar.
AI-generated summary by SENS-AI, based on the original JSE SENS filing.
SENS-AI conclusion
The headline numbers are bad, but the market had already priced much of the deterioration in — the share sold off 25.7% into the print and the trading statement 19 days earlier had flagged the decline. The real new information is the cash-flow damage: cash conversion collapsed to 70% while capex surged 73.6%, which is a deterioration the guidance did not quantify. This is confirmation of a weak half rather than a fresh shock, and the absence of quantified H2 guidance leaves the recovery story unanchored. So what: the market still needs evidence that the Montagu integration and Cape Herb consolidation actually restore cash generation, not just EBITDA.
The H2 2026 results are where the market will test whether cash conversion recovers and the integration benefits materialise.
Evidence from the filing
Normalised EBITDA of R453.2m landed within the trading statement range of R446.1m-R460.3m, meeting the bar set 19 days earlier.
“Normalised EBITDA 453 165 -4.3% 473 768 (margin) 7.8% 8.2%”
Post-period disposal of the Phesantekraal property raised R65m, incrementally strengthening an already conservative balance sheet.
“Transfer occurred after the reporting date, on 31 July 2026, raising proceeds of R65 million, which further strengthened the Group balance sheet”
Cash conversion collapsed to 70% from 107%, signalling severe deterioration in cash generation far worse than the 4.3% EBITDA decline.
“Cash conversion ratio 70% 107%”
Basic EPS fell 47.3% to 8.8 cents and Basic HEPS fell 29.1% to 12.9 cents, with Normalised EPS also down 13.4% — earnings power is materially impaired.
“Basic EPS (cents) 8.8 -47.3% 16.7 Basic HEPS (cents) 12.9 -29.1% 18.2”
Capex surged 73.6% to R145.3m while cash from operations dropped 31.9% to R342.8m, compressing free cash flow and raising funding pressure.
“Capital investment in property, plant and equipment 145 333 73.6% 83 717”
Value-added Meats remains structurally under pressure from chicken capacity constraints and beef underutilisation, with the manufacturing capacity review only due to complete in H2 2026 — the fix is deferred.
“remains structurally under pressure from these challenges, necessitating a detailed manufacturing capacity review which is due to be completed in H2 2026”
More on Libstar Holdings Limited
Related filings
More from LBR
- LIBSTAR HOLDINGS LIMITED - Trading Statement for the Six Months Ended 30 June 2026
- LIBSTAR HOLDINGS LIMITED - Appointment of Group Chief Operating Officer
- LIBSTAR HOLDINGS LIMITED - Voluntary Pre-Close Trading Update for the 21-week Period ended 31 May 2026 and Investor Conference Call
- LIBSTAR HOLDINGS LIMITED - Dealings in Securities by an Executive Director of Libstar
- LIBSTAR HOLDINGS LIMITED - Results of the Annual General Meeting of Shareholders
Other Results
- SPGSUPER GROUP LIMITED - Summarised Financial Final Results and Cash Dividend Declaration for the year ended 30 June 2026
- OMUOLD MUTUAL LIMITED - Unaudited interim results and interim dividend declaration for the six months ended 30 June 2026
- CCCCILO CYBIN HOLDINGS LIMITED - Audited Annual Consolidated Financial Statements for the Financial year ended 31 March 2026, Distribution of Integrated Annual Report and Notice of Annual General Meeting, and Availability of B-BBEE Annual Compliance Report
- SUISUN INTERNATIONAL LIMITED - Unaudited Interim Group Financial Results, Interim Ordinary Cash Dividend Declaration for the six months ended 30 June 2026 and Changes to Risk Committee Responsibilities
- AVIAVI LIMITED - RESULTS FOR THE YEAR ENDED 30 JUNE 2026, AND FINAL AND SPECIAL DIVIDEND